anti-neo ibook questions Flashcards
MOA: produce metal chelating complex to induce free radicals to damage phosphodiester bond of DNA
bleomycin
MOA: DNA damaged by quinone induced free radicals, ROS and H2O2
rubicins
MOA: intercalate DNA
rubicins
MOA: block topoisomerase II
rubicins, etoposide, teniposide
AE: cardiotoxicity, extravasation, and dose-limiting myelosuppression
rubicins
AE: pulmonary fibrosis and hyperpigmentation
Bleomycin
AE: infusion reactions, hypotension, hypersensitivity
paclitaxel and etoposide
AE: dose-limiting myelosuppression
topotecan, vinblastine, pacitaxel
AE: severe myelosuppression
teniposide, topotecan, vinblastine, pacitaxel
AE: diarrhea
irinotecan, 5-FU
AE: peripheral neuropathy
paclitaxel and vincristine
MOA: block topoisomerase II
etoposide and teniposide
MOA: block topoisomerase I
topotecan and irinotecan
MOA: inhibits microtubule polymerization
vincristine and vinblastine
MOA: inhibits dissociation of microtubules
paclitaxel and docetaxel, other taxanes
MOA: thymidine inhibitor
capecitibine and 5-FU
MOA: cytidine inhibitor
cytarabine
MOA: purine inhibitor
6-MP
MOA: folate inhibitor
MTX
AE: hand and foot syndrome
5-FU and capecitibine
AE: crystalluria
MTX
AE: severe myelosuppression
MTX and 5-FU
HGPRT enzyme to make fraudulent nucleotides
6-MP
DHFR enzyme
MTX
Thymidylate phosphorylase
capecitibine
Thymidylate synthetase
5-FU
DNA polymerase
Ara C (cytarabine)
Rituximab target
CD20
Natalizumab target
alpha 4 integrin
Trastuzumab and pertuzumab target
HER-2
Alemtuzimab target
CD52
AE of Alemtuzimab
severe long term myelosuppression